Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: June 7, 2023
Freezing
of
gait
(FOG)
is
common
in
neurodegenerative
forms
atypical
parkinsonism,
but
few
studies
have
examined
FOG
multiple
system
atrophy
(MSA).
In
this
study,
we
the
prevalence
freezing
and
its
relationship
to
clinical
features
a
large
cohort
Chinese
MSA
patients.This
exploratory
study
included
202
patients
with
probable
MSA.
was
defined
as
score
≥
1
on
item
14
Unified
Parkinson's
Disease
Rating
Scale.
Patients
or
without
were
compared
terms
Scale
(UMSARS)
well
cognitive
neuropsychiatric
assessments.The
frequency
48.0,
52.1,
38.7%
MSA,
predominant
parkinsonism
(MSA-P),
cerebellar
ataxia
(MSA-C),
respectively.
associated
worse
subscores
parts
I,
II
IV
UMSARS
total
score;
greater
likelihood
speech
difficulties,
falls,
impairment
balance
disorder;
more
severe
symptoms
anxiety
depression;
lower
activities
daily
living.
The
binary
logistic
regression
model
indicated
that
higher
scores
MSA-P,
MSA-C
patients.Freezing
may
be
among
patients,
correlate
motor
symptoms,
anxiety,
depression
Total
an
independent
risk
factor
for
FOG.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(6), P. e0304788 - e0304788
Published: June 14, 2024
Objectives
To
describe
changes
in
balance,
walking
speed,
functional
mobility,
and
eye
movements
following
an
activity-oriented
physiotherapy
(AOPT)
or
its
combination
with
movement
training
(AOPT-E)
patients
Parkinson’s
disease
(PD).
explore
the
feasibility
of
a
full-scale
randomised
controlled
trial
(RCT).
Methods
Using
assessor-blinded
pilot
RCT,
25
PD
were
allocated
to
either
AOPT
AOPT-E.
Supervised
interventions
performed
30
minutes,
4x/weekly,
for
4
weeks,
alongside
inpatient
rehabilitation.
Outcomes
assessed
at
baseline
post-intervention,
including
dynamic
dual-task
ability
safely
health-related
quality
life
(HRQoL),
depression,
(number/duration
fixations)
using
mobile
tracker.
Freezing
gait
(FOG),
falls-related
self-efficacy
baseline,
4-week
follow-up.
Effect
sizes
0.10
considered
weak,
0.30
moderate,
≥0.50
strong.
Feasibility
was
predefined
criteria:
recruitment,
retention
adherence
rates,
adverse
events,
falls,
post-intervention
acceptability
qualitative
interviews.
Results
Improvements
observed
balance
(effect
size
r
=
0.216–0.427),
speed
(r
0.165),
mobility
0.306–0.413),
0.247),
HRQoL
0.024–0.650),
depression
0.403).
Falls-related
0.621)
FOG
0.248)
showed
varied
improvements,
partly
sustained
Eye
improvements
after
AOPT-E
only.
analysis
revealed
that
recruitment
below
target,
less
than
two
recruited
per
month
due
COVID-19
restrictions.
targets
met,
rate
96%
(95%
confidence
interval
[CI]:
77.68–99.79)
98.18%
CI:
96.12–99.20)
rate,
exceeding
80%
75%,
respectively.
One
event
unrelated
study
intervention
confirmed
safety,
interview
data
indicated
high
acceptability.
Conclusions
appeared
be
effective
PD.
larger
RCT
is
needed
validate
results.
Journal of Parkinson s Disease,
Journal Year:
2024,
Volume and Issue:
14(s1), P. S193 - S207
Published: July 19, 2024
People
with
Parkinson's
disease
(PD)
experience
a
range
of
progressive
motor
and
non-motor
symptoms,
that
negatively
affect
their
daily
functioning,
social
participation
quality
life.
Allied
health
therapies
have
emerged
as
an
effective
treatment
approach-complementary
to
pharmacological
neurosurgical
treatments-which
reduces
the
impact
PD
in
In
this
article,
we
propose
criteria
for
what
constitutes
specialized
allied
care
PD,
review
research
terms
meeting
these
its
outcomes
monodisciplinary
approaches
well
multi-
or
interdisciplinary
interventions.
We
focus
on
three
most
studied
disciplines
PD:
physical
therapy,
occupational
therapy
speech-language
therapy.
Overall,
available
evidence
underscores
importance
potential
benefits
people
PD.
Our
proposed
recommendations
future
might
help
further
delineating
care.
Retos,
Journal Year:
2024,
Volume and Issue:
59, P. 172 - 186
Published: July 26, 2024
Objetivo:
Caracterizar,
através
de
uma
revisão
sistemática,
a
influência
diferentes
tipologias
pistas
(auditiva,
visual,
tátil)
no
desempenho
da
dupla-tarefa
na
Doença
Parkinson.
Metodologia:
A
pesquisa
primária
foi
realizada
nas
bases
dados
PubMed,
Scopus
e
Science
Direct.
Os
estudos
foram
incluídos
acordo
com
os
critérios
elegibilidade:
(i)
artigos
publicados
em
revistas/jornais
científicos;
(ii)
nos
últimos
10
anos;
(iii)
escritos
língua
portuguesa,
espanhola
inglesa;
(iv)
inclusão
participantes
doença
Parkinson,
mesmo
que
grupos
mistos,
mas
específicos
dupla
tarefa;
(v)
descrição
intervenção
tarefa.
Resultados:
13
nesta
sistemática:
5
boa
qualidade,
7
qualidade
razoável,
um
pobre.
Verifica-se
maior
utilização
visuais,
6
estudos;
3
auditivas;
2
táteis
audiovisuais.
Relativamente
à
tarefa:
8
realizaram
tarefa
cognitiva,
motora
efetuaram
ambas.
Apenas
usaram
medidas
correlação
entre
o
presente
demonstra
as
(visuais
motoras)
melhoram
características
espaciotemporais
marcha
Parkinson
tarefa,
por
outro
lado,
representa
exigência
planeamento
do
movimento.
Conclusão:
Esta
sistemática
identificou
significativa
variabilidade
metodologias
usadas.
As
visuais
destacam-se
pela
sua
mais
frequente
De
forma
geral,
parece
aumentar
nestes
pacientes.
Palavras-chave:
Neuromuscular;
Reabilitação;
Terapia
pelo
Exercício;
Retorno;
Sensorial
Healthcare,
Journal Year:
2024,
Volume and Issue:
12(16), P. 1636 - 1636
Published: Aug. 16, 2024
Gait
dysfunction
(GD)
is
a
common
impairment
of
Parkinson's
disease
(PD),
which
negatively
impacts
patients'
quality
life.
Among
the
most
recent
rehabilitation
technologies,
lower-limb
powered
exoskeleton
(LLEXO)
arises
as
useful
instrument
for
gait
training
in
several
neurological
conditions,
including
PD.
However,
some
questions
relating
to
methods
use,
achievable
results,
and
usefulness
compared
traditional
methodologies
still
require
clear
answers.
Therefore,
this
review,
we
aim
summarise
analyse
all
studies
that
have
applied
an
LLEXO
train
PD
patients.
Literature
research
on
PubMed
Scopus
retrieved
five
articles,
comprising
46
participants
stable
medications
(age:
71.7
±
3.7
years,
24
males,
Hoehn
Yahr:
2.1
0.6).
Compared
rehabilitation,
low-profile
(lp-LLEXO)
brought
major
improvements
towards
walking
capacity
speed,
while
there
are
no
benefits
regarding
dual-task
cost
index
freezing
symptoms.
Importantly,
results
suggest
lp-LLEXO
more
beneficial
patients
with
intermediate-to-severe
level
severity
(Hoehn
Yahr
>
2.5).
This
review
could
provide
novel
framework
implementing
clinical
practise,
highlighting
its
limitations
training.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 11, 2024
SCIENTIFIC
ABSTRACT
Introduction
Current
treatments
for
patients
with
Parkinson’s
disease
(PwP)
can
fail
to
address
gait
disturbance
and
falls,
which
in
turn
affect
quality
of
life
(QoL).
The
CUE1
device
delivers
cueing
vibrotactile
stimulation
showing
potential
alleviate
motor
symptoms
reduce
falls
based
on
preliminary
user
testing
results.
Objectives
To
evaluate
the
feasibility,
safety,
tolerability
its
effect
non-motor
PwP.
Methods
PwP
used
9-weeks
were
assessed
at
week
0,
3,
6,
9
MDS-UPDRS
Part-III,
Timed
Up
Go
(TUG),
TUG
dual
task
(DT),
Functional
Gait
Assessment
(FGA),
Bradykinesia
Akinesia
Incoordination
(BRAIN)
test.
Patients
reported
outcomes
through
Part-I,
-II,
-IV
Pittsburgh
Sleep
Quality
Index
(PSQI).
Results
Ten
(5
females,
age
range:
46-80;
duration:
3-9
years)
completed
intervention
100%
compliance
no
adverse
events.
comfort
usability
rated
highly
(80%).
Immediate
was
observed
MDS-UPDRS-
III(45.40±12.22
vs
39.60±11.74,
p=0.008),
TUG(11.53±1.92
11.08±1.94,
p=0.022),
DT(18.57±5.75
17.61±6.28,
p=0.037)
FGA(16.40±3.86
18.60±3.92,
p=0.007).
Cumulative
noted
MDS-UPDRS-III(45.40±12.22
27.80±12.32,
p=0.005),
FGA(18.60±3.92
23.10±
2.85,
p<0.001),
13.58±7.05,
p=0.031),
BRAIN
kinesia
(45.10±14.39
42.10±12.74,
p<0.001)
incoordination
(24331.09±38017.46
14059.91±
9030.96,
p=0.016)
scores,
PSQI(10.10±4.95
6.90±3.81,
p=0.002),
MDS-UPDRS-I(18.60±6.75
12.20±3.68,
p=0.011),
II(17.30±7.29
11.90±8.67,
MDS-UPDRS-IV(7.50±3.75
3.40±2.95,
p=0.003).
Conclusion
In
this
unblinded,
feasibility
study,
appeared
be
a
feasible
safe
improving
features.
PLAIN
Background
This
study
looked
use
called
CUE1,
provides
rhythmic
pulsing
vibration
help
movement
non-movement
people
(PwP).
Even
current
treatments,
issues
walking
falling
still
many
patients.
goal
see
if
could
helpful,
safe,
easy-to-use
tool
symptoms,
like
risk
falling,
as
well
sleep.
Procedures
women,
aged
46-80)
who
had
years
weeks.
Everyone
finished
using
regularly
negative
side
effects.
80%
ease
use.
Significant
improvements
seen
abilities
(using
MDS-UPDRS-III
test),
speed,
fall
risk.
Over
weeks,
participants
showed
further
progress
movement,
balance,
coordination.
Non-movement
sleep,
also
improved.
Conclusions
device,
gentle
vibrations
assist
found
easy
use,
effective.
It
improved
both
movement-related
balance
walking,
makes
it
promising
new
treatment
option
Parkinson’s.
Clinical Parkinsonism & Related Disorders,
Journal Year:
2024,
Volume and Issue:
11, P. 100284 - 100284
Published: Jan. 1, 2024
Dual-task
(DT)
performance
is
impaired
in
Parkinson's
disease
(PD),
contributing
to
bradykinesia,
postural
instability,
freezing
of
gait,
and
falls.
Tactile
cueing,
including
vibrotactile
stimulation,
has
been
suggested
improve
DT
PD.